Equities Analysts Issue Forecasts for MD FY2025 Earnings

Pediatrix Medical Group, Inc. (NYSE:MD) – Research analysts at Zacks Research boosted their FY2025 earnings estimates for Pediatrix Medical Group in a research report issued on Thursday, March 6th. Zacks Research analyst Z. Masood now expects that the company will post earnings per share of $1.39 for the year, up from their previous estimate of $1.20. The consensus estimate for Pediatrix Medical Group’s current full-year earnings is $1.38 per share. Zacks Research also issued estimates for Pediatrix Medical Group’s FY2026 earnings at $1.43 EPS.

A number of other equities research analysts also recently weighed in on the stock. StockNews.com upgraded shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. UBS Group lifted their price target on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a research note on Friday, February 21st. Macquarie began coverage on shares of Pediatrix Medical Group in a research note on Monday, December 16th. They set an “outperform” rating and a $18.00 price target on the stock. Truist Financial lifted their price target on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a research note on Friday, February 21st. Finally, Mizuho lifted their price target on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 19th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $17.08.

Pediatrix Medical Group Trading Down 2.4 %

Shares of Pediatrix Medical Group stock opened at $14.01 on Monday. Pediatrix Medical Group has a 1 year low of $6.62 and a 1 year high of $17.67. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The company’s fifty day simple moving average is $14.12 and its 200-day simple moving average is $13.37. The company has a market cap of $1.20 billion, a price-to-earnings ratio of -11.67, a PEG ratio of 1.74 and a beta of 1.48.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.12. The business had revenue of $502.36 million for the quarter, compared to the consensus estimate of $486.22 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in MD. Pacer Advisors Inc. bought a new position in shares of Pediatrix Medical Group during the fourth quarter valued at $35,492,000. American Century Companies Inc. raised its holdings in shares of Pediatrix Medical Group by 628.2% in the fourth quarter. American Century Companies Inc. now owns 1,739,323 shares of the company’s stock valued at $22,820,000 after buying an additional 1,500,485 shares during the last quarter. Oberweis Asset Management Inc. bought a new position in shares of Pediatrix Medical Group in the fourth quarter valued at about $6,122,000. Renaissance Technologies LLC raised its holdings in shares of Pediatrix Medical Group by 117.4% in the fourth quarter. Renaissance Technologies LLC now owns 838,800 shares of the company’s stock valued at $11,005,000 after buying an additional 453,000 shares during the last quarter. Finally, Boston Partners raised its holdings in shares of Pediatrix Medical Group by 25.2% in the fourth quarter. Boston Partners now owns 1,956,353 shares of the company’s stock valued at $25,922,000 after buying an additional 393,600 shares during the last quarter. 97.71% of the stock is owned by institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.